Efficacy and safety of evogliptin in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A multicentre, double‐blind, randomized, comparative trial. Issue 4 (27th December 2021)

Record Type:: Journal Article
Title:: Efficacy and safety of evogliptin in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A multicentre, double‐blind, randomized, comparative trial. Issue 4 (27th December 2021)
Main Title:: Efficacy and safety of evogliptin in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A multicentre, double‐blind, randomized, comparative trial
Authors:: Han, Eugene
Huh, Ji Hye
Lee, Eun Y.
Bae, Ji C.
Chun, Sung W.
Yu, Sung H.
Kwak, Soo H.
Park, Kyong S.
Lee, Byung‐Wan
Abstract:
Is Part Of:: Diabetes, obesity & metabolism. Volume 24:Issue 4(2022)
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 24:Issue 4(2022)
Issue Display:: Volume 24, Issue 4 (2022)
Year:: 2022
Volume:: 24
Issue:: 4
Issue Sort Value:: 2022-0024-0004-0000
Page Start:: 752
Page End:: 756
Publication Date:: 2021-12-27
Subjects:: dipeptidyl peptidase‐4 inhibitor -- evogliptin -- magnetic resonance imaging‐derived proton density fat fraction -- non‐alcoholic fatty liver disease -- pioglitazone -- type 2 diabetes
Diabetes -- Periodicals
Obesity -- Periodicals
Metabolism -- Disorders -- Periodicals
Clinical pharmacology -- Periodicals
616.462
Journal URLs:: http://www.blackwellpublishing.com/journal.asp?ref=1462-8902&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1463-1326 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/dom.14623 ↗
Languages:: English
ISSNs:: 1462-8902
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3579.601970
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21066.xml